Sheng-Yu Yao

Sheng-Yu Yao

Auto-generated profile, based on publicly available information

Sheng-Yu Yao

Department of General Surgery, QiLu Hospital, Shandong University, Jinan, Shandong, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2022 in Journal of Clinical and Translational Hepatology
Verified
Journal Article
Open access
LYLun-Jie Yan
Lun-Jie Yan
SYSheng-Yu Yao
Sheng-Yu Yao
HLHai-Chao Li
Hai-Chao Li
GMGuang-Xiao Meng
Guang-Xiao Meng
KLKai-Xuan Liu
Kai-Xuan Liu
TLTao Li
Tao Li
Previous meta-analyses have shown that aspirin use may reduce the risk of hepatocellular carcinoma (HCC). However, the optimal dose, frequency, and duration of aspirin use or the safety and efficacy of aspirin in target populations for HCC prevention remain unclear. The study aim was to investigate the efficacy and safety of aspirin for prevention of HCC.